Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings.

[1]  R. Ehman,et al.  3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence , 2018, Journal of magnetic resonance imaging : JMRI.

[2]  C. Strassburg,et al.  Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma , 2018, PLoS ONE.

[3]  D. Ketelsen,et al.  Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT. , 2017, Academic radiology.

[4]  Hong-Yu Zhang,et al.  The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors. , 2017, Clinics and research in hepatology and gastroenterology.

[5]  S. Ahn,et al.  Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation , 2017, Journal of gastroenterology and hepatology.

[6]  R. Ehman,et al.  MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings. , 2017, Magnetic resonance imaging.

[7]  K. Nikolaou,et al.  Comparison between acoustic radiation force impulse quantification data and perfusion-CT parameters in hepatocellular carcinoma. , 2017, European journal of radiology.

[8]  P. Sutphin,et al.  Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma , 2017, Journal of computer assisted tomography.

[9]  B. Taouli,et al.  Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy , 2017, Abdominal Radiology.

[10]  J. Geschwind,et al.  Intra-arterial therapies for liver cancer: assessing tumor response , 2017, Expert review of anticancer therapy.

[11]  Chia-Yang Hsu,et al.  Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[12]  R. Lencioni,et al.  Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data , 2016, Hepatology.

[13]  Z. Ren,et al.  Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells , 2016, Oncotarget.

[14]  Chiun Hsu,et al.  Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges , 2016, Liver Cancer.

[15]  H. Alkadhi,et al.  Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment , 2016, CardioVascular and Interventional Radiology.

[16]  Z. Ren,et al.  Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma , 2014, BMC Cancer.

[17]  S. Ahn,et al.  Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy , 2014, The American Journal of Gastroenterology.

[18]  A. Ahuja,et al.  Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound , 2014, BioMed research international.

[19]  Yan Luo,et al.  Effects of vascularity and differentiation of hepatocellular carcinoma on tumor and liver stiffness: in vivo and in vitro studies. , 2014, Ultrasound in medicine & biology.

[20]  S. Ye,et al.  Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria , 2014, BMC Gastroenterology.

[21]  P. Zhou,et al.  Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity. , 2013, Hepatobiliary & pancreatic diseases international : HBPD INT.

[22]  J. Geschwind,et al.  Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? , 2013, Radiology.

[23]  S. Ahn,et al.  Characterization of focal liver masses using acoustic radiation force impulse elastography. , 2013, World journal of gastroenterology.

[24]  V. Mazzaferro,et al.  Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions , 2012, Seminars in Liver Disease.

[25]  G. Nunnari,et al.  Acoustic Radial Force Impulse as an effective tool for a prompt and reliable diagnosis of hepatocellular carcinoma - preliminary data. , 2012, European review for medical and pharmacological sciences.

[26]  K. Nam,et al.  Comparative Study of Shear Wave Velocities Using Acoustic Radiation Force Impulse Technology in Hepatocellular Carcinoma: The Extent of Radiofrequency Ablation , 2012, Gut and liver.

[27]  M. Friedrich-Rust,et al.  Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[28]  K. Nam,et al.  Acoustic radiation force impulse elastography for hepatocellular carcinoma-associated radiofrequency ablation. , 2011, World journal of gastroenterology.

[29]  Daniel Benten,et al.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells , 2011, Hepatology.

[30]  R. Goertz,et al.  Characterization of Focal Liver Lesions (FLL) with Acoustic Radiation Force Impulse (ARFI) Elastometry , 2010, Ultraschall in der Medizin.

[31]  A. Benson,et al.  Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Wells.  The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[33]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[34]  Ming-hua Li,et al.  Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. , 2004, World journal of gastroenterology.

[35]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[36]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.